Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram N Ganapathi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|August 6, 2013
Mechanisms regulating resistance to inhibitors of topoisomerase IIRam N Ganapathi, Mahrukh K Ganapathi
Genome Medicine|January 4, 2012
Predicting responses to sunitinib using single nucleotide polymorphisms: Progress and recommendations for future trialsRam N Ganapathi, Ronald M Bukowski
Gynecologic Oncology|March 10, 2016
Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancerKatherine R Miller, Jai N Patel, Mahrukh K Ganapathi, et al.
Frontiers in Oncology|September 25, 2020
Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian CancerRam N Ganapathi, Eric J Norris, Ashley P Sutker, et al.
Cancers|March 12, 2020
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female CancersWendell D Jones, Chad M Michener, Charles Biscotti, et al.
The Journal of Pathology|March 19, 2019
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinomaEric J Norris, Qing Zhang, Wendell D Jones, et al.
International Journal of Cancer|August 28, 2015
Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancerMahrukh K Ganapathi, Wendell D Jones, Jalid Sehouli, et al.
British Journal of Cancer|October 16, 2018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerJai N Patel, Ioana Braicu, Kirsten M Timms, et al.
Gynecologic Oncology Reports|June 13, 2018
Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1Eric J Norris, Wendell D Jones, Marius D Surleac, et al.
Nucleic Acids Research|May 5, 2017
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpointToshiyuki Kozuki, Kenichi Chikamori, Marius D Surleac, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|August 6, 2013
Mechanisms regulating resistance to inhibitors of topoisomerase IIRam N Ganapathi, Mahrukh K Ganapathi
Genome Medicine|January 4, 2012
Predicting responses to sunitinib using single nucleotide polymorphisms: Progress and recommendations for future trialsRam N Ganapathi, Ronald M Bukowski
Gynecologic Oncology|March 10, 2016
Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancerKatherine R Miller, Jai N Patel, Mahrukh K Ganapathi, et al.
Frontiers in Oncology|September 25, 2020
Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian CancerRam N Ganapathi, Eric J Norris, Ashley P Sutker, et al.
Cancers|March 12, 2020
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female CancersWendell D Jones, Chad M Michener, Charles Biscotti, et al.
The Journal of Pathology|March 19, 2019
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinomaEric J Norris, Qing Zhang, Wendell D Jones, et al.
International Journal of Cancer|August 28, 2015
Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancerMahrukh K Ganapathi, Wendell D Jones, Jalid Sehouli, et al.
British Journal of Cancer|October 16, 2018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerJai N Patel, Ioana Braicu, Kirsten M Timms, et al.
Gynecologic Oncology Reports|June 13, 2018
Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1Eric J Norris, Wendell D Jones, Marius D Surleac, et al.
Nucleic Acids Research|May 5, 2017
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpointToshiyuki Kozuki, Kenichi Chikamori, Marius D Surleac, et al.
Pageof 2